BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
11/18/2026 5:34:53 AM | Browse: 1 | Download: 0
Publication Name World Journal of Cardiology
Manuscript ID 126612
Country Taiwan
Received
2026-08-10 09:04
Peer-Review Started
2026-08-10 09:04
First Decision by Editorial Office Director
Return for Revision
2026-08-25 07:42
Revised
2026-09-04 16:46
Publication Fee Transferred
Editorial Processing by Scientific Editor
2026-10-28 07:35
Final Academic Decision by Editor-in-Chief
Publication Technical Verification by Editorial Office Director
2026-10-28 10:26
Articles in Press
2026-10-28 10:26
Edit the Manuscript by Language Editor
Typeset the Manuscript
2026-11-10 09:27
Publish the Manuscript Online
2026-11-18 05:34
ISSN 1949-8462 (online)
Open Access Open-Access: This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution-NonCommercial (CC BY-NC 4.0) license. No commercial re-use. See Permissions. Published by Baishideng Publishing Group Inc.
Copyright ©Author(s) (or their employer(s)) 2026. No commercial re-use. See Permissions. Published by Baishideng Publishing Group Inc.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Cardiac & Cardiovascular Systems
Manuscript Type Minireviews
Article Title Coenzyme Q10 for heart failure and symptomatic cardiovascular diseases
Manuscript Source Invited Manuscript
All Author List Yen-Chen Lin, Wei-Chieh Huang, Chun-Tsai Tsai, Kai-Ti Yang, Yun-Chen Chang, Yen-Po Lin, Wei-Chun Huang and Gen-Min Lin
ORCID
Author(s) ORCID Number
Yen-Po Lin http://orcid.org/0000-0003-2798-3978
Gen-Min Lin http://orcid.org/0000-0002-5509-1056
Funding Agency and Grant Number
Funding Agency Grant Number
Hualien Armed Forces General Hospital, Taiwan HAFGH-D-115004
Corresponding Author Gen-Min Lin, Director, FACC, FAHA, FESC, Department of Medicine, Hualien Armed Forces General Hospital, No. 100 Jinfeng Street, Hualien 970, Taiwan. farmer507@yahoo.com.tw
Key Words Coenzyme Q10; Heart failure; Ischemic heart disease; Mitochondrial dysfunction; Statins; Microvascular angina
Core Tip Coenzyme Q10 (CoQ10) plays a dual role in cardiomyocyte bioenergetics and antioxidant defense. In heart failure (HF) and ischemic heart disease, CoQ10 deficiency exacerbates energy starvation and oxidative stress. Evidence from trials like Q-SYMBIO underscores its ability to reduce mortality and hospitalizations in patients with HF with reduced ejection fraction. Additionally, CoQ10 mitigates statin-induced myopathy and cardiomyopathy. Emerging applications in microvascular angina and HF with preserved ejection fraction represent promising frontiers requiring further clinical evaluation.
Publish Date 2026-11-18 05:34
Citation

Lin YC, Huang WC, Tsai CT, Yang KT, Chang YC, Lin YP, Huang WC, Lin GM. Coenzyme Q10 for heart failure and symptomatic cardiovascular diseases. World J Cardiol 2026; 18(11): 126612

URL https://www.wjgnet.com/1949-8462/full/v18/i11/126612.htm
DOI https://doi.org/10.4330/wjc.126612
Full Article (PDF) WJC-18-126612-with-cover.pdf